President-elect Donald Trump’s HHS appointees represent a broad spectrum of healthcare perspectives and are poised to significantly influence public health, pharmaceuticals and health systems.
With a $1.8 trillion budget in 2024, the department’…
Category: ROOT
Trump's plans for HHS: 13 knowns
Watchdog flags flaws in FDA's fast-track drug approvals
A new report from HHS’ Office of Inspector General raises concerns about the FDA’s accelerated approval process for drugs with weak supporting evidence, Bloomberg reported Jan. 14.
Mercy Health-Springfield's key to reducing infections
As president of Mercy Health-Springfield (Ohio), Adam Groshans is prioritizing employee retention and quality and access improvements in 2025, building on momentum from the organization’s 2024 achievements.
How wildfires tested — and demonstrated — City of Hope's resilience
The Eaton fire broke out in Altadena, Calif., on the morning of Jan. 8, just eight miles from City of Hope’s main campus in Duarte, Calif., where about 230 cancer patients were hospitalized.
Florida system names 3 C-suite leaders
Clearwater, Fla.-based BayCare has appointed a new C-suite leader and updated the roles and titles of two others.
Long-term hospitals with highest, lowest preventable readmission rates
Thornton, Colo.-based Vibra Hospital of Denver has the lowest potentially preventable readmission rate among long-term care hospitals, according to CMS data.
Quality, cost-effective healthcare can’t wait
Across America, medically necessary, lifesaving surgeries are being cancelled or delayed due to a shortage of anesthesia providers. Americans deserve high-quality, timely healthcare. Certified registered nurse anesthetists (CRNAs) play a crucial role i…
Rhode Island hospital names chief nursing officer
The Miriam Hospital in Providence, R.I., has named Seanna Zimmerman, DNP, RN, vice president and chief nursing officer.
GI's changing regulatory landscape
The last 12 months saw major regulatory changes for the field of gastroenterology, from new FDA approvals to sweeping statewide and national legislation.
Insulin prices at 10-year low: GoodRx
The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report.
